Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions

Cites (473)

Items 401–471 of 471

1. Identifying novel factor XIIa inhibitors with PCA-GA-SVM developed vHTS models
   Jonathan Jun Feng Chen, Donald P. Visco · 2017 · European Journal of Medicinal Chemistry
2. Computer-aided design of novel antibacterial 3-hydroxypyridine-4-ones: application of QSAR methods based on the MOLMAP approach
   Razieh Sabet, Afshin Fassihi, Bahram Hemmateenejad, Lotfollah Saghaei, Ramin Miri, Maryam Gholami · 2012 · Journal of Computer-Aided Molecular Design
3. A rotation-translation invariant molecular descriptor of partial charges and its use in ligand-based virtual screening
   Francois Berenger, Arnout R. D. Voet, Xiao Yin Lee, Kam Y. J. Zhang · 2014 · Journal of Cheminformatics
4. Computational systems biology approaches for Parkinson’s disease
   Enrico Glaab · 2017 · Cell and Tissue Research
5. Functional ultrasound imaging to study brain dynamics: Application of pharmaco-fUS to atomoxetine
   Benjamin Vidal, Marine Droguerre, Ludovic Venet, Luc Zimmer, Marco Valdebenito, Franck Mouthon, Mathieu Charvériat · 2020 · Neuropharmacology
6. Predicting adverse drug reactions of two‐drug combinations using structural and transcriptomic drug representations to train an artificial neural network
   Susmitha Shankar, Ishita Bhandari, David T. Okou, Gowri Srinivasa, Prashanth Athri · 2020 · Chemical Biology & Drug Design
7. The perilous path from publication to practice
   Adam Mourad Chekroud, Nikolaos Koutsouleris · 2017 · Molecular Psychiatry
8. Drug repurposing with network reinforcement
   Yonghyun Nam, Myung-Jun Kim, Hang‐Seok Chang, Hyunjung Shin · 2019 · BMC Bioinformatics
9. An Automated Algorithm Incorporating Poincaré Analysis Can Quantify the Severity of Opioid-Induced Ataxic Breathing
   Sean C. Ermer, Robert J. Farney, Ken B. Johnson, Joseph A. Orr, Talmage D. Egan, Lara Brewer · 2020 · Anesthesia & Analgesia
10. Automatic assessment of medication states of patients with Parkinson's disease using wearable sensors
    Murtadha D. Hssayeni, Michelle A. Burack, Behnaz Ghoraani · 2016
11. Prediction of N-Methyl-D-Aspartate Receptor GluN1-Ligand Binding Affinity by a Novel SVM-Pose/SVM-Score Combinatorial Ensemble Docking Scheme
    Max K. Leong, Ren-Guei Syu, Yi-Lung Ding, Ching‐Feng Weng · 2017 · Scientific Reports
12. Pharmaco-fUS for Characterizing Drugs for Alzheimer’s Disease – The Case of THN201, a Drug Combination of Donepezil Plus Mefloquine
    Benjamin Vidal, Marine Droguerre, Marco Valdebenito, Luc Zimmer, M. Hamon, Franck Mouthon, Mathieu Charvériat · 2020 · Frontiers in Neuroscience
13. Prediction of drug synergy in cancer using ensemble-based machine learning techniques
    Harpreet Singh, Prashant Singh Rana, Urvinder Singh · 2018 · Modern Physics Letters B
14. Potential identification of vitamin B6 responsiveness in autism spectrum disorder utilizing phenotype variables and machine learning methods
    Taku Obara, Mami Ishikuro, Gen Tamiya, Masao Ueki, Chizuru Yamanaka, Satoshi Mizuno, Masahiro Kikuya, Hirohito Metoki, Hiroko Matsubara, Masato Nagai et al. · 2018 · Scientific Reports
15. Chemogenomic Analysis of the Druggable Kinome and Its Application to Repositioning and Lead Identification Studies
    Balaguru Ravikumar, Sanna H. Timonen, Zaid Alam, Elina Parri, Krister Wennerberg, Tero A. Aittokallio · 2019 · Cell chemical biology
16. Analysis of defective pathways and drug repositioning in Multiple Sclerosis via machine learning approaches
    Enrique J. deAndrés‐Galiana, Guillermina Bea, Juan Luis Fernández‐Martínez, Leorey N. Saligan · 2019 · Computers in Biology and Medicine
17. Predicting Deep Hypnotic State From Sleep Brain Rhythms Using Deep Learning: A Data-Repurposing Approach
    Sunil Belur Nagaraj, Sowmya Muchukunte Ramaswamy, Maud A. S. Weerink, Michel M. R. F. Struys · 2020 · Anesthesia & Analgesia
18. FDA approves galantamine for Alzheimer’s disease
    Cheryl A. Thompson · 2001 · American Journal of Health-System Pharmacy
19. QSAR Accelerated Discovery of Potent Ice Recrystallization Inhibitors
    Jennie G. Briard, Michael Fernández, Phil De Luna, Tom K. Woo, Robert N. Ben · 2016 · Scientific Reports
20. QSAR Modelling to Identify LRRK2 Inhibitors for Parkinson’s Disease
    Víctor Sebastián-Pérez, María Jimena Martínez, Carmen Gil, Nuria Eugenia Campillo, Ana Martı́nez, Ignacio Ponzoni · 2019 · Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics
21. Integrating Clinical Data and Imputed Transcriptome from GWAS to Uncover Complex Disease Subtypes: Applications in Psychiatry and Cardiology
    Liangying Yin, Carlos Kwan‐Long Chau, Pak Chung Sham, Hon‐Cheong So · 2019 · The American Journal of Human Genetics
22. Comprehensive Exploration of Target‐specific Ligands Using a Graph Convolution Neural Network
    Yu Miyazaki, Naoaki Ono, Ming Huang, Md. Altaf‐Ul‐Amin, Shigehiko Kanaya · 2019 · Molecular Informatics
23. Virtual Screening of CB 2 Receptor Agonists from Bayesian Network and High‐Throughput Docking: Structural Insights into Agonist‐Modulated GPCR Features
    Nicolas Renault, Xavier Laurent, Amaury Farce, Jamal El Bakali, Roxane M. Mansouri, Philippe P. Gervois, Régis Millet, Pierre Desreumaux, Christophe Furman, Philippe Chavatte · 2012 · Chemical Biology & Drug Design
24. Machine Learning Scoring Functions Based on Random Forest and Support Vector Regression
    Pedro J. Ballester · 2012 · Lecture notes in computer science
25. Fingerprint Design And Engineering Strategies: Rationalizing And Improving Similarity Search Performance
    Kathrin Heikamp, Jürgen Bajorath · 2012 · Future Medicinal Chemistry
26. Prediction and Optimization of NaV1.7 Sodium Channel Inhibitors Based on Machine Learning and Simulated Annealing
    Weikaixin Kong, Xinyu Tu, Weiran Huang, Yang Yang, Zhengwei Xie, Zhuo Huang · 2020 · Journal of Chemical Information and Modeling
27. EEG Beta-Band Spectral Entropy Can Predict the Effect of Drug Treatment on Pain in Patients With Herpes Zoster
    Mengying Wei, Yuliang Liao, Jia Liu, Linling Li, Gan Huang, Jiabin Huang, Disen Li, Lizu Xiao, Zhiguo Zhang · 2020 · Journal of Clinical Neurophysiology
28. Combinatorial Library Enumeration and Lead Hopping using Comparative Interaction Fingerprint Analysis and Classical 2D QSAR Methods for Seeking Novel GABAA α3 Modulators
    Ramachandran Vijayan, Indrani Bera, Prabu Manoharan, Sangita Saha, Nanda Ghoshal · 2009 · Journal of Chemical Information and Modeling
29. AlzhCPI: A knowledge base for predicting chemical-protein interactions towards Alzheimer’s disease
    Jiansong Fang, Ling Wang, Yecheng Li, Wenwen Lian, Xiaocong Pang, Hong Wang, Dongsheng Yuan, Qi Wang, Ailin Liu, Guanhua Du · 2017 · PLoS ONE
30. Synergistic drug combinations prediction by integrating pharmacological data
    Zhang Cheng-zhi, Guiying Yan · 2019 · Synthetic and Systems Biotechnology
31. Neural networks for protein structure and function prediction and dynamic analysis
    Yuko Tsuchiya, Kentaro Tomii · 2020 · Biophysical Reviews
32. Discovering Molecular Functional Groups Using Graph Convolutional Neural Networks
    Pope, Phillip, Soheil Kolouri, Rostrami, Mohammad, Charles E. Martin, Heiko Hoffmann · 2018 · arXiv (Cornell University)
33. Finding Needles in a Haystack: Determining Key Molecular Descriptors Associated with the Blood‐brain Barrier Entry of Chemical Compounds Using Machine Learning
    Subhabrata Majumdar, Subhash C. Basak, Claudiu Nicolae Lungu, Mircea Vasile Diudea, Gregory D. Grunwald · 2019 · Molecular Informatics
34. Identification of novel class I and class IIb histone deacetylase inhibitor for Alzheimer's disease therapeutics
    Rohan V. Gupta, Rashmi K. Ambasta, Pravir Kumar · 2020 · Life Sciences
35. In SilicoInvestigation of Traditional Chinese Medicine Compounds to Inhibit Human Histone Deacetylase 2 for Patients with Alzheimer’s Disease
    Tzu-Chieh Hung, Wen‐Yuan Lee, Kuen‐Bao Chen, Yueh-Chiu Chan, Cheng-Chun Lee, Calvin Yu‐Chian Chen · 2014 · BioMed Research International
36. Relation path feature embedding based convolutional neural network method for drug discovery
    Di Zhao, Jian Wang, Shengtian Sang, Hongfei Lin, Jiabin Wen, Chunmei Yang · 2019 · BMC Medical Informatics and Decision Making
37. Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces
    Yi Zheng, Hui Peng, Xiaocai Zhang, Zhixun Zhao, Xiaoying Gao, Jinyan Li · 2019 · BMC Bioinformatics
38. Classification of Opioid Usage Through Semi-Supervised Learning for Total Joint Replacement Patients
    Sujee Lee, Shujing Wei, Veronica M. White, Philip A. Bain, Christine Baker, Jingshan Li · 2020 · IEEE Journal of Biomedical and Health Informatics
39. Ligand-based virtual screen for the discovery of novel M5 inhibitor chemotypes
    Alexander R. Geanes, Hykeyung P. Cho, Kellie D. Nance, Kevin M. McGowan, Peter Jeffrey Conn, Carrie K. Jones, Jens Meiler, Craig W. Lindsley · 2016 · Bioorganic & Medicinal Chemistry Letters
40. Improving virtual screening predictive accuracy of Human kallikrein 5 inhibitors using machine learning models
    X. M. Fang, Sikha S. Bagui, Subhash Bagui · 2017 · Computational Biology and Chemistry
41. Genome-wide prediction and prioritization of human aging genes by data fusion: a machine learning approach
    Masoud Arabfard, Mina Ohadi, Vahid Rezaei Tabar, Ahmad Delbari, Kaveh Kavousi · 2019 · BMC Genomics
42. Systems biology-based approaches to summarize and identify novel genes and pathways associated with acute and chronic postsurgical pain
    Vidya Chidambaran, Maria E. Ashton, Lisa Joy Martin, Anil Goud Jegga · 2020 · Journal of Clinical Anesthesia
43. Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles
    Miguel Pinto, Carlos Fernandes, Eva Gil-Martins, Renata Silva, Sofia Benfeito, Fernando Cagide, Ricardo F. Mendes, Filipe A. Almeida Paz, Jorge Garrido, Fernando Remião et al. · 2019 · Pharmaceutics
44. Multimodale Erkennung von Schmerzintensität und -modalität mit maschinellen Lernverfahren
    Steffen Walter, Ayoub K. Al-Hamadi, Sascha Gruss, Stephan Frisch, H. C. Traue, Philipp Werner · 2020 · Der Schmerz
45. Reducing Opioid Prescriptions by Identifying Responders on Topical Analgesic Treatment Using an Individualized Medicine and Predictive Analytics Approach
    Jeffrey A. Gudin, Seferina P. Mavroudi, Aigli Korfiati, Konstantinos Theofilatos, Derek T. Dietze, Peter L Hurwitz · 2020 · Journal of Pain Research
46. Structure‐Based Target‐Specific Screening Leads to Small‐Molecule CaMKII Inhibitors
    David Daqiang Xu, Liwei Li, Donghui Zhou, Degang Liu, Andy Hudmon, Samy O. Meroueh · 2017 · ChemMedChem
47. Neural Network Modeling of AChE Inhibition by New Carbazole-Bearing Oxazolones
    Levent Çavaş, Gamze Topcam, Cevher Gündoğdu Hızlıateş̨, Yavuz Ergün · 2017 · Interdisciplinary Sciences Computational Life Sciences
48. Effects of lactate on the early visual cortex of non-human primates, investigated by pharmaco-MRI and neurochemical analysis
    Veronika von Pföstl, Juan Li, Daniel Zaldivar, Jozien B. M. Goense, Xiaozhe Zhang, Nadine Serr, Nikos K. Logothetis, Alexander Rauch · 2012 · NeuroImage
49. Atom Type Preferences, Structural Diversity, and Property Profiles of Known Drugs, Leads, and Nondrugs: A Comparative Assessment
    Vellarkad N. Viswanadhan, Hariharan Rajesh, Vitukudi N. Balaji · 2011 · ACS Combinatorial Science
50. Multi-targeting Drug Community Challenge
    Avner Schlessinger, Ruben A Abagyan, Heather A. Carlson, Kristen K. Dang, Justin Guinney, Ross Leigh Cagan · 2017 · Cell chemical biology
51. PLATYPUS: A Multiple—View Learning Predictive Framework for Cancer Drug Sensitivity Prediction
    Kiley S. Graim, Verena Friedl, Kathleen E. Houlahan, Joshua M. Stuart · 2018 · Pacific Symposium on Biocomputing (PSB)
52. Artificial neural network modeling of antimycobacterial chemical space to introduce efficient descriptors employed for drug design
    Soroush Sardari, H H Kohanzad, Ghazaleh Ghavami · 2013 · Chemometrics and Intelligent Laboratory Systems
53. A Random Forest Model to Predict the Activity of a Large Set of Soluble Epoxide Hydrolase Inhibitors Solely Based on a Set of Simple Fragmental Descriptors
    Jamal Shamsara · 2019 · Combinatorial Chemistry & High Throughput Screening
54. Robotic anesthesia - a vision for the future of anesthesia.
    Thomas M. Hemmerling, Riccardo Taddei, Mohamad Wehbe, Joshua Morse, Shantale Cyr, Cédrick Zaouter · 2011 · Europe PMC (PubMed Central)
55. Drug Targets, Target Identification, Validation, and Screening
    Walter M.M. Van den Broeck · 2015 · Elsevier eBooks
56. Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivity
    Kai-Cheng Hsu, Feng‐Sheng Wang · 2017 · PLoS ONE
57. Inferring Drug-Related Diseases Based on Convolutional Neural Network and Gated Recurrent Unit
    Ping Xuan, Lianfeng Zhao, Tiangang Zhang, Yilin Ye, Yan Zhang · 2019 · Molecules
58. Crowdsourced mapping extends the target space of kinase inhibitors
    Anna Cichońska, Balaguru Ravikumar, Robert J. Allaway, Sung‐Joon Park, Fang Wan, Olexandr Isayev, Shuya Li, Mike J. Mason, Andrew E. Lamb, Ziaurrehman Tanoli et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
59. Developing a Multi-target Model to Predict the Activity of Monoamine Oxidase A and B Drugs
    Riccardo Concu, Michael González‐Durruthy, M. Natália D. S. Cordeiro · 2020 · Current Topics in Medicinal Chemistry
60. Improved tracking of sevoflurane anesthetic states with drug-specific machine learning models
    Kimia Kashkooli, Sam L. Polk, Eunice Y. Hahm, James M. Murphy, Breanna R. Ethridge, Jacob Gitlin, Reine Ibala, Jennifer Mekonnen, Juan Cristóbal Pedemonte, Haoqi Sun et al. · 2020 · Journal of Neural Engineering
61. Insights into Pharmacotherapy Management for Parkinson's Disease Patients Using Wearables Activity Data
    Vincent Grigori Nguyen, Kunz Holger, Paul M. Taylor, Dionisio Acosta · 2018 · Studies in health technology and informatics
62. G2P: Using machine learning to understand and predict genes causing rare neurological disorders
    Juan Antonio Botía, Sebastian Guelfi, David Zhang, Karishma D’Sa, Regina Hertfelder Reynolds, Daniel F. O. Onah, Ellen M. McDonagh, Antonio Rueda Martin, Arianna Tucci, Augusto Rendon et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
63. Predicting protein structural features with artificial neural networks
    Stephen R. Holbrook, Steven M. Muskal, Sung‐Hou Kim · 1993 · American Association for Artificial Intelligence eBooks
64. Prediction of anti-cancer drug response by kernelized multi-task learning
    Mehmet Tan · 2017
65. Predicting alternatively spliced exons using semi-supervised learning
    Ana Stanescu, Karthik Tangirala, Doina Caragea · 2015 · International Journal of Data Mining and Bioinformatics
66. Detecting the Potential Pharmacological Synergy of Drug Combination by Viability Assays In Vitro
    Benjamin K. Gibbs, Carole Sourbier · 2017 · Methods in molecular biology
67. Pain-CKB, A Pain-Domain-Specific Chemogenomics Knowledgebase for Target Identification and Systems Pharmacology Research
    Zhiwei Feng, Maozi Chen, Mingzhe Shen, Tianjian Liang, Hui Chen, Xiang‐Qun Xie · 2020 · Journal of Chemical Information and Modeling
68. Prediction of permeability of drug-like compounds across polydimethylsiloxane membranes by machine learning methods
    Basheerulla Shaik, Rachna Gupta, Bruno Louis, Vijay K. Agrawal · 2015 · Journal of Pharmaceutical Investigation
69. Guest editorial: Special issue on machine learning in schizophrenia
    M. Mallar Chakravarty · 2019 · Schizophrenia Research
70. Extraction of Protein Dynamics Information Hidden in Cryogenic Electron Microscopy Maps Using Deep Learning
    Shigeyuki Matsumoto, Shoichi Ishida, Mitsugu Araki, Takayuki Kato, Kei Terayama, Yasushi Okuno · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
71. Science unfolding in time: a situated protein folding landscape in retrospect
    Alexander Powell · 2019